Have a feature idea you'd love to see implemented?
Let us know!
LIVN LivaNova PLC
Price (delayed)
$47.63
Market cap
$2.59B
P/E Ratio
108.25
Dividend/share
N/A
EPS
$0.44
Enterprise value
$2.59B
LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through
Highlights
LivaNova's revenue has increased by 11% YoY and by 2.6% from the previous quarter
The gross profit has grown by 10% YoY and by 2.9% from the previous quarter
LivaNova's quick ratio has increased by 9% YoY but it has decreased by 3.3% QoQ
LIVN's debt is up by 9% year-on-year
Key stats
What are the main financial stats of LIVN
Market
Valuations
Earnings
Shares outstanding
54.3M
Market cap
$2.59B
Enterprise value
$2.59B
Price to earnings (P/E)
108.25
Price to book (P/B)
1.97
Price to sales (P/S)
2.08
EV/EBIT
6,123.14
EV/EBITDA
47.21
EV/Sales
2.09
Revenue
$1.24B
Gross profit
$841.69M
Net income
$23.68M
EBIT
$423,000
EBITDA
$54.86M
Free cash flow
$108.67M
Per share
Balance sheet
Liquidity
EPS
$0.44
EPS diluted
$0.42
Free cash flow per share
$2
Book value per share
$24.13
Revenue per share
$22.85
TBVPS
$27.45
Total assets
$2.52B
Total liabilities
$1.21B
Debt
$670.32M
Equity
$1.31B
Working capital
$768.71M
Debt to equity
0.51
Current ratio
3.37
Quick ratio
2.66
Net debt/EBITDA
0.07
Margins
Efficiency
Dividend
EBITDA margin
4.4%
Gross margin
67.8%
Net margin
1.9%
Operating margin
0.3%
Return on assets
1%
Return on equity
1.9%
Return on invested capital
0%
Return on capital employed
0%
Return on sales
0%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LIVN stock price
How has the LivaNova stock price performed over time
Intraday
0.66%
1 week
1.28%
1 month
-7.51%
1 year
-6.95%
YTD
2.85%
QTD
2.85%
Financial performance
How have LivaNova's revenue and profit performed over time
Revenue
$1.24B
Gross profit
$841.69M
Operating income
$4.04M
Net income
$23.68M
Gross margin
67.8%
Net margin
1.9%
The company's operating income has surged by 115% QoQ but it has shrunk by 88% YoY
LivaNova's operating margin has surged by 114% QoQ but it has shrunk by 90% YoY
LivaNova's revenue has increased by 11% YoY and by 2.6% from the previous quarter
The gross profit has grown by 10% YoY and by 2.9% from the previous quarter
Growth
What is LivaNova's growth rate over time
Valuation
What is LivaNova stock price valuation
P/E
108.25
P/B
1.97
P/S
2.08
EV/EBIT
6,123.14
EV/EBITDA
47.21
EV/Sales
2.09
The price to book (P/B) is 21% lower than the 5-year quarterly average of 2.5 and 14% lower than the last 4 quarters average of 2.3
The equity rose by 7% year-on-year and by 5% since the previous quarter
The price to sales (P/S) is 31% lower than the 5-year quarterly average of 3.0 and 13% lower than the last 4 quarters average of 2.4
LivaNova's revenue has increased by 11% YoY and by 2.6% from the previous quarter
Efficiency
How efficient is LivaNova business performance
LivaNova's return on sales has surged by 100% QoQ but it has shrunk by 100% YoY
The ROIC has soared by 100% from the previous quarter but it has plunged by 100% YoY
Dividends
What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LIVN.
Financial health
How did LivaNova financials performed over time
The company's total assets is 108% higher than its total liabilities
LivaNova's total liabilities has increased by 10% YoY
LivaNova's quick ratio has increased by 9% YoY but it has decreased by 3.3% QoQ
LIVN's debt is 49% smaller than its equity
LIVN's debt is up by 9% year-on-year
The equity rose by 7% year-on-year and by 5% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.